¿Síntomas repentinos de un ataque cerebral? Llame al 911 de inmediato.

Horario · Lun–vie, 8 a. m.–5 p. m.

Wled Wazni, MD — Currículum vitae

CARGO ACTUAL

  • 2018 Director médico del programa de accidentes cerebrovasculares, St Mary Medical Center-LB
  • 2021 Director médico del programa de accidentes cerebrovasculares, Glendale Memorial Hospital-Glendale

CARGO ANTERIOR

  • 7/01/2017 Rochester General Hospital | Rochester Regional Health, New York
    Cirujano neuroendovascular, médico de plantilla

FORMACIÓN DE POSGRADO

  • 7/01/16-6/30/17 Froedtert & Medical College of Wisconsin, Milwaukee, Wisconsin
    Subespecialidad en cirugía neuroendovascular
  • 7/01/14-6/30/16 Froedtert & Medical College of Wisconsin, Milwaukee, Wisconsin
    Subespecialidad en cuidados neurocríticos (certificación de UCNS)
  • 7/01/13- 6/30/14 Froedtert & Medical College of Wisconsin, Milwaukee, Wisconsin
    Subespecialidad en neurología vascular (certificación de ABPN)
  • 7/01/10- 6/30/13 Hofstra-North Shore-LIJ School of Medicine, Manhasset, New York
    Residencia en neurología
  • 7/01/09-6/30/10 DMC/Wayne State University School of Medicine, Detroit, Michigan
    Internado, año de transición en medicina

EDUCACIÓN

  • 2004-2008 American University of the Caribbean, St Maarten, Netherlands Antilles
    Título de medicina
  • 2000-2004 Western Michigan University, Kalamazoo, Michigan
    Estudios de comunicación interpersonal

AFILIACIONES PROFESIONALES

  • Society of Vascular and Interventional Neurology
  • Society of Neurointerventional Surgery — Miembro sénior
  • Society of Critical Care Medicine
  • American Academy of Neurology

EXÁMENES Y CERTIFICACIONES

  • 2022 ABNS RFP en procedimientos endovasculares del sistema nervioso central
  • 2021 Certificación de especialidad en cuidados neurocríticos
  • 2018 Certificación de especialidad en neurología vascular
  • 2014 Certificación de especialidad en neurología
  • 2016 ACLS - American Heart Association 2016 BLS- American Heart Association

LICENCIA MÉDICA

  • California — Activa
  • New York — Activa
  • Wisconsin — Activa
  • Michigan — Inactiva

PUBLICACIONES

  • Wazni W, Zaidat O. Middle Meningeal Artery Embolization for Intractable Migraines: A Groundbreaking Approach. Journal of Vascular and Interventional Neurology. 2025;16(1). Serie de casos.
  • Seizure Prophylaxis in the Immediate Post-Hemorrhagic Period in Patients with Aneurysmal Sub-arachnoid Hemorrhage. Kodankandath TV, Farooq S, Wazni W, Cox JA, Southwood C, Rozansky G, Johnson V, Lynch JR. Journal of Vascular Interventional Neurology. 2017 Dec;9(6):1-4.
  • Anterior Communicating Artery aneurysm treatment with the Pipeline Embolization Device: a single-center experience with long-term follow up. Sultan A, Wazni W, Zaidat O, Sattar A, Noufal, M. Inter-ventional neurology. Interventional Neurology. 2017 Feb;22;6:126-134.
  • Outcome Predictors After Successful Intra-Arterial Therapy for Acute Ischemic Stroke (P1.195) Mazen Noufal, Jigar Mankad, Amrita Amanda Lakraj, John-Andrew Cox, David Shirilla, Ahsan Sattar, Wled Wazni, Yamin Sallowm, John Lynch and Osama Zaidat. Neurology journals. 2016 April; 5 Suppl 16:86.
  • Validation of a New Modified Capillary Index Score Angiographic Real Time Assessment of Dead vs Salvable Tissue. Teleb M, Noufal M, Sattar A, Wazni W, Issa M, Asif K, Gheith A, Castonguay A, Zai-dat O. J Neurointerv Surg. 2014 Jul;6 Suppl 1:A71.

CAPÍTULOS DE LIBROS

  • Zaidat OO, Wazni W, Sattar A. Chapter 4:Intra-Arterial Therapy for Acute Ischemic Stroke, In: Ischem-ic Stroke Therapeutics: A Comprehensive Guide, Ovbiagele, Bruce, Turan, Tanya (Editors), Springer Co.

PRESENTACIONES DE RESÚMENES

  • Spinal Dural Arteriovenous Fistula: Long Term Clinical And Radiographic Outcomes With Endovascular Therapy Alone In A Single Academic Center. Christopher S, Noufal M, Sattar A,Wazni W, YaminnS, Lazzaro M, Lynch J, Zaidat O, Fitzsimmons BF. Platform presentation at the Society of Vascular and Interventional Neurology annual meeting, Bonita Springs, Florida, October 2015.
  • Bilateral Persistent Trigeminal Arteries Ending in PICA: First Reported Anatomical Variant Described on Diagnostic Cerebral Angiogram. Wled Wazni, Mazen Noufal, Ashan Sattar, Ali Abdal-lah, Alicia Castonguay, Osama Zadiat. Poster presentation at the Society of Vascular and Interventional Neurology annual meeting, Bonita Springs, Florida, October 2015.
  • Age, stroke severity, use of stent retrievers, general anesthesia, and hemorrhagic conversion may pre-dict outcome in stroke patients who undergo successful intra-arterial therapy. M Noufal, J Mankad, D Shirilla, A Lakraj, J Cox, A Sattar, W Wazni, Y Sallowm, J Lynch, O Zaidat. SNIS 12th Annual Meet-ing, July 2015.
  • Safety and Efficacy of the Pipeline Embolization in the Treatment of Anterior Communicating Artery Aneurysms. Sultan A, Wazni W, Zaidat O, Sattar A, Noufal, M. Poster presentation at the Society of Vascular and Interventional Neurology annual meeting, Brooklyn, New York, November 2016.
  • Sensitivity of Arterial Spin-Labeling in Detecting Delayed Cerebral Ischemia in Patients with Aneu-rysmal SAH for presentation at the NCS 15th Annual Meeting, Waikoloa Village, Hawaii 2017.

INVESTIGACIÓN CLÍNICA

  • Interés actual de investigación: uso de la perfusión por resonancia magnética para identificar el vasoespasmo tardío en pacientes con hemorragia subaracnoidea aneurismática tratados con cirugía endovascular.

Experiencia previa en investigación

Coinvestigador

  • • SWIFT PRIME: Solitaire FR With The Intention For Thrombectomy As Primary Endovascular Treatment For Acute Ischemic Stroke
  • • THERAPY: The Randomized, Concurrent Controlled Trial to Assess the Penumbra System’s Safety and Effectiveness in the Treatment of Acute Stroke
  • • SEPARATOR 3D: A Randomized, concurrent controlled trial to assess the safety and effective-ness of the Separator 3D as a component of the Penumbra System in the revascularization of large vessel occlusion in acute ischemic stroke
  • • SOCRATES: Acute Stroke Or Transient Ischemic Attack Treated with Aspirin or Ticagrelor and Patient Outcomes
  • • ATACH-II: Antihypertensive Treatment in Acute Cerebral Hemorrhage-II
  • • CLEAR III: Clot Lysis: Evaluating Accelerated Resolution of Intraventricular Hemorrhage Phase III Intraventricular Hemorrhage study
  • • MISTIE III: A phase III, randomized, open-label, 500-subject clinical trial of minimally invasive surgery plus rt-PA in the treatment of intracerebral hemorrhage.
  • • LIBERTY TRIAL: The Penumbra Liberty Trial: Safety and Effectiveness in the Treatment of Wide-Neck Intracranial Aneurysms
  • • ACE: An Aneurysm Coiling Efficiency Study of the Penumbra Coil 400 System
  • • GELATIN: HydroGel Balloon Assisted Aneurysm Coiling
  • • SCENT: The Surpass IntraCranial Aneurysm Embolization System Pivotal Trial to Treat Large or Giant Wide Neck Aneurysms
  • • TRANSFORM: Occlusion Balloon Catheter Neuro Interventinal procedures that require Bal-loon catheter
  • • ACTION: Effect of Natalizumab on Infarct Volume in Acute Ischemic Stroke
  • • ASPIRe: Aneurysm Study of Pipeline in an Observational Registry
  • • WEAVE: Wingspan Stent System Post Market Surveillance Study
  • • TREVO: Trevo Retriever Registry Post Market Surveillance
  • • TARGET: Intracranial Aneurysm Coiling Prospective Multicenter Registry
  • • STRATIS: Systematic Evaluation of Patients Treated With Neurothrombectomy Devices for Acute Ischemic Stroke Registry
Llamar al consultorioSolicitar cita